Tuesday, March 10

Healthcare

Organon downgraded, Amneal upgraded as J.P. Morgan reviews specialty pharma

09/07/20241 Min Read

Amneal downgraded J.P Morgan Organon Pharma reviews specialty upgraded

Previous ArticlePsyence Biomedical to acquire drug developer Clairvoyant

Next Article Axogen completes marketing submission for Avance Nerve Graft